Semaglutide/NAD+ 2.5mg/50mg — Greenstone Peptides
USA Compoundedinjectable

Semaglutide/NAD+ 2.5mg/50mg

Synergistic combination of semaglutide and NAD+ for weight loss with metabolic optimization.

Strength
2.5mg/50mg
Size
5mL
Format
injectable
Price
$150

These products are intended for research and educational purposes only. They have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption. Read full disclaimer

Description

What is the Semaglutide + NAD+ Combination?

This formulation combines two distinct therapeutic agents into a single compounded vial: semaglutide, a GLP-1 receptor agonist for appetite regulation and weight management, and NAD+ (Nicotinamide Adenine Dinucleotide), a coenzyme essential for cellular energy production and metabolic function. Together, they address two complementary aspects of metabolic health — caloric regulation and cellular energy — in one convenient preparation.

How It Works

Semaglutide works via GLP-1 receptor activation to reduce appetite, slow gastric emptying, and support weight loss. NAD+ addresses the cellular energy side of metabolism — supporting mitochondrial function, DNA repair, and the enzymatic reactions that govern how efficiently the body processes nutrients and produces energy. While semaglutide reduces caloric intake, NAD+ supports the cells' ability to use that energy more efficiently.

Key Benefits

Patients pursuing weight management often find that as weight decreases, fatigue can be a transient challenge. The addition of NAD+ to a semaglutide protocol may help support energy levels throughout the weight loss process. Research on each individual component is robust — NAD+ and GLP-1 therapies have both been studied extensively on their own. This combination offers the convenience of a single-vial protocol for patients already using both agents.

What to Expect

The combination is administered as a weekly subcutaneous injection, following the same titration approach as standalone semaglutide. Patients often report the energy-supporting effects of NAD+ as a complement to the appetite-suppressing effects of semaglutide — particularly during the early weeks of therapy when dietary changes are most significant. Dosing and protocol design should be managed by a licensed prescribing physician.

Quality & Sourcing

Every semaglutide/NAD+ combination formulation from Greenstone Peptides is compounded in the USA by licensed pharmacy partners under USP 797 sterile standards. Each batch is third-party tested for potency, sterility, and endotoxin.

Storage

Refrigerate at 2–8°C. Protect from light.